Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669 for 2.0 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by educational grants from AstraZeneca, Genomic Health, Inc, and Lilly.

For further information concerning Lilly grant funding, visit

LIVE WEBCAST: School of Breast Oncology®: 2018 Mid-Year Video Update

LIVE WEBCAST: School of Breast Oncology®: 2018 Mid-Year Video Update

Monday, August 27, 2018
8:00 PM to 10:00 PM EST




Join us online for the School of Breast Oncology®: 2018 Mid-Year Video Update, a live-stream, interactive broadcast featuring leading experts in the field of breast cancer who will provide a comprehensive overview of noteworthy data presented at recent international society meetings. An expert panel will also discuss and debate the clinical application of these data and the future direction of the treatment landscape in breast cancer. This program is an extension of the annual School of Breast Oncology®, and it provides an additional forum for clinicians to keep pace with rapidly emerging data and advancing treatment paradigms in breast cancer.

We would be delighted to have you take part in this exciting event, which will offer education to augment your foundation of knowledge and clinical competence in several areas, including:

  • Integrating prognostic genomic assays to individualize treatment selection for early-stage, HR+/HER2- breast cancers
  • Evolving paradigms in (neo)adjuvant therapy for HR+, HER2+, and triple-negative breast cancers
  • Clinical insights regarding endocrine, cytotoxic, targeted, and immunotherapeutic agents for the treatment of metastatic breast cancer, including current treatment options and emerging agents
  • Trends, challenges, and controversies in the locoregional management of early-stage and locally advanced breast cancers

The format of this live online broadcast is an in-studio panel discussion where experts present highlights of key data, followed by discussion and debate about key concepts and clinical applications in breast cancer. In addition, you will have multiple opportunities to engage with the faculty through submission of questions and/or cases to be discussed by the panel during the live session. Register today and bring medical conference‒caliber education to the convenience of your screen.

Benefits of attending

  • Insights into using predictive and prognostic biomarkers for treatment selection
  • Tactics for individualizing therapy for early-stage and locally advanced breast cancers
  • Strategies for integrating new agents for metastatic disease
  • Innovations in locoregional management approaches
  • Opportunities to submit questions to the faculty on the practical applications of new data

Acknowledgment of Commercial Support

This activity is supported by education grants from AstraZeneca, Daiichi Sankyo, Inc., Genomic Health, Inc., Lilly, Merck Sharp & Dohme Corp., Novartis Pharmaceuticals Corporation, Pfizer, and Puma Biotechnology, Inc.

For further information concerning Lilly grant funding, visit

Target Audience

This educational activity is directed toward medical, surgical, and radiation oncologists involved in the treatment and management of patients with breast cancer. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other healthcare professionals interested in the treatment of breast cancer may also participate.

Learning Objectives

  • Assess recently presented efficacy and safety data from clinical trials conducted in the setting of breast cancer
  • Explain key recent findings concerning tumor testing to help optimize care for patients with breast cancer
  • Appraise recent evidence regarding treatment sequencing and combination strategies for patients who may be candidates for new therapies for breast cancer
  • Develop evidence-based treatment plans for patients with breast cancer, incorporating new treatment options when appropriate

Program Director

Joyce O'Shaughnessy, MD
Celebrating Women Chair in Breast Cancer Research
Baylor University Medical Center
Texas Oncology
Chair, Breast Cancer Research Program
The US Oncology Network
Dallas, TX


You must be logged in to PER to register for this meeting

Or Register for PER now

*Required Fields

Login Information

Registration Information

Professional Information


Calendar of Events
Filter By